CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence

Each CYP2A6 gene variant metabolizes nicotine differently depending on its enzymatic activities. The normal nicotine metabolizer CYP2A6(*)1A is associated with high scores of nicotine dependence (5–10) on the Fagerström Test for Nicotine Dependence (FTND) scale because it encodes for enzymes that ca...

Descripción completa

Detalles Bibliográficos
Autor principal: Akrodou, Yawo Mawuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427762/
https://www.ncbi.nlm.nih.gov/pubmed/26060595
http://dx.doi.org/10.1155/2015/491514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427762/
https://www.ncbi.nlm.nih.gov/pubmed/26060595
http://dx.doi.org/10.1155/2015/491514

Ejemplares similares